Global Tinea Corporis Market is expected to rise steadily at a CAGR of 7.2% during forecast period of 2018-2023.
Tinea corporis is a fungal infection that is caused by tinea rubrum, trichophyton mentagrophytes and epidermophyton floccosum fungi. This fungal infection mainly occurs in humid climatic condition. It is also known as ringworm infection. Tinea corporis infection occurs mostly on arms, legs or can also occur on different parts of body.
The global tinea corporis market is expected to see the growth in upcoming year due to entry of new drug product in market for treatment. Many key players in market are engaged in development of new drug product for tinea corporis treatment.
Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6838
Tinea corporis is contagious infection which can spread from one person to other hence it is important not to share towel, flannels, bathmats with another person.
Top Industry Key players:
Some of the key players in the global tinea corporis market are
- Taro Pharmaceuticals. Inc.
- Teva Pharmaceuticals Inc.
- Glenmark Pharmaceuticals Inc
- Breckenridge Pharmaceutical Inc.
- NorthStar Rx LLC
- Aurobindo Pharma Limited
- and Camber Pharmaceuticals Inc.
- AvKare Inc.
- Novartis AG
- Sebela Pharmaceuticals Inc.
- Bayer AG
- Blueberry Therapeutics Ltd
- Perrigo Company.
Global tinea corporis market is segmented into drug type, diagnosis, treatment and end-users.
Global Tinea Corporis Market by Drug Type
- Anti-Infective Combinations
Global Tinea Corporis Market, by Diagnosis
- Physical Exam
- Imaging Tests
- Wood lamp (black light) examination
- Microscopy using potassium hydroxide (KOH)
- Fungal culture
- Skin biopsy
Browse Complete Premium Research Report Enabled with TOC at https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838
Global Tinea Corporis Market, by Treatment
- Antifungal shampoos
- Antifungal creams
Global Tinea Corporis Market, by End-Users
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
- Dermatology hospitals
Regional Market Summary
Geographically, the America holds the highest market share for tinea corporis market and the reason being many market players are engaged in development of new drug product innovation, and as this infection is more prone to humid climatic condition there is an increasing prevalence of fungal infection in this region. Whereas increasing awareness of fungal disease and rising healthcare expenditure by the government are some of the factors responsible for growth of market in this region
Europe is expected to be the second largest market in the globe owing to the increasing aging population, increasing prevalence of fungal infection, focus on aesthetic appearance, increasing research base. Whereas rise in susceptible immune compromised patient population is responsible for market growth in this region.
Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of fungal infection, changing lifestyle, increase in population, increasing healthcare expenditure by government are some of the factor responsible for market growth in this region.
Ask for an Amazing Discount at https://www.marketresearchfuture.com/check-discount/6838
- Manufacturers and Suppliers
- Hospitals and Clinics
- Laboratories and Associations
- Research Institutes
- Dermatology Clinics
About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312